Mar 9, 2023

Model illuminates environmental cues that may contribute to breast cancer recurrence

Posted by in category: biotech/medical

Nearly 270,000 people in the United States are diagnosed with breast cancer each year.

According to the Susan G. Komen Foundation, about 70%–80% of these individuals experience estrogen receptor-positive (ER+) breast cancer, where need estrogen to grow. In terms of treatment, this presence of hormone receptors provides a nice handle for targeting tumors, say with therapies that knock out the tumor cell’s ability to bind to estrogen and prevent remaining from growing.

However, even if treated successfully, on average, one in five individuals with ER+ breast cancer experience a late recurrence when dormant in distant parts of the body, such as the , reactivate anywhere from five to over 20 years after .

Comments are closed.